DIANE E. SULLIVAN

Corporate Board Profile

Tech Score: 0/100

LEXICON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2024-03-26	Diane E. Sullivan has been a director since July 2023 and founded her own consulting firm. Ms. Sullivan provides us with the benefit of her extensive experience in the pharmaceutical industry. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Diane E. Sullivan and Judith L. Swain, M.D. The following table presents summary information for the year ended December 31, 2023 regarding the compensation of the non-employee members of our board of directors. Diane E. Sullivan received $25,747 in fees and $150,670 in stock awards in 2023, totaling $176,417.

Filing Date

Source Excerpt

2024-03-26

Diane E. Sullivan has been a director since July 2023 and founded her own consulting firm. Ms. Sullivan provides us with the benefit of her extensive experience in the pharmaceutical industry. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Diane E. Sullivan and Judith L. Swain, M.D. The following table presents summary information for the year ended December 31, 2023 regarding the compensation of the non-employee members of our board of directors. Diane E. Sullivan received $25,747 in fees and $150,670 in stock awards in 2023, totaling $176,417.

Data sourced from SEC filings. Last updated: 2026-03-09